2/6
06:00 am
ntra
Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes
Low
Report
Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes
2/3
10:02 am
ntra
Alger Weatherbie Specialized Growth Fund Q4 2025 Winners And Laggards [Seeking Alpha]
Low
Report
Alger Weatherbie Specialized Growth Fund Q4 2025 Winners And Laggards [Seeking Alpha]
2/2
06:00 am
ntra
Natera Submits Signatera™ CDx PMA to FDA
Low
Report
Natera Submits Signatera™ CDx PMA to FDA
1/31
07:19 am
ntra
A Look At The Fair Value Of Natera, Inc. (NASDAQ:NTRA) [Yahoo! Finance]
Low
Report
A Look At The Fair Value Of Natera, Inc. (NASDAQ:NTRA) [Yahoo! Finance]
1/28
08:00 am
ntra
Natera Announces Completion of Enrollment in Randomized ACES-EMB Trial in Heart Transplantation
Low
Report
Natera Announces Completion of Enrollment in Randomized ACES-EMB Trial in Heart Transplantation
1/26
06:00 am
ntra
Prospera™ Featured in Landmark Interventional Study Advancing Lung Transplant Care
Low
Report
Prospera™ Featured in Landmark Interventional Study Advancing Lung Transplant Care
1/21
06:00 am
ntra
Natera Publishes Clinical Validation of Latitude™ Tissue-Free MRD Test in Colorectal Cancer
Medium
Report
Natera Publishes Clinical Validation of Latitude™ Tissue-Free MRD Test in Colorectal Cancer
1/20
06:00 am
ntra
Natera’s Fetal Focus™ Single Gene NIPT (sgNIPT) Selected for Prestigious Oral Plenary Presentation at Society of Maternal Fetal Medicine (SMFM) Meeting
Medium
Report
Natera’s Fetal Focus™ Single Gene NIPT (sgNIPT) Selected for Prestigious Oral Plenary Presentation at Society of Maternal Fetal Medicine (SMFM) Meeting
1/13
08:00 am
ntra
Natera Announces Next Breakthrough in MRD-Based Risk Stratification, Leveraging Multi-Modal AI Modeling
Low
Report
Natera Announces Next Breakthrough in MRD-Based Risk Stratification, Leveraging Multi-Modal AI Modeling
1/12
10:00 am
ntra
Natera to Scale AI Foundation Models in Precision Medicine with NVIDIA
Low
Report
Natera to Scale AI Foundation Models in Precision Medicine with NVIDIA
1/12
07:17 am
ntra
Natera (NASDAQ:NTRA) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
Low
Report
Natera (NASDAQ:NTRA) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
1/11
10:48 pm
ntra
Natera Announces Strong Preliminary Fourth Quarter and 2025 Financial Results Driven by Record Signatera™ Growth
Medium
Report
Natera Announces Strong Preliminary Fourth Quarter and 2025 Financial Results Driven by Record Signatera™ Growth
1/11
09:22 am
ntra
Breakeven On The Horizon For Natera, Inc. (NASDAQ:NTRA) [Yahoo! Finance]
Medium
Report
Breakeven On The Horizon For Natera, Inc. (NASDAQ:NTRA) [Yahoo! Finance]
1/10
05:43 am
ntra
Natera (NASDAQ:NTRA) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
Medium
Report
Natera (NASDAQ:NTRA) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
1/8
04:01 pm
ntra
Octave Bioscience Expands Leadership Team with Appointment of Kirk Stockwood Senior Vice President, Commercial
Low
Report
Octave Bioscience Expands Leadership Team with Appointment of Kirk Stockwood Senior Vice President, Commercial
1/7
10:58 am
ntra
Natera (NASDAQ:NTRA) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Low
Report
Natera (NASDAQ:NTRA) had its "buy" rating reaffirmed by analysts at Cowen Inc.
1/7
06:05 am
ntra
Natera (NASDAQ:NTRA) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
Low
Report
Natera (NASDAQ:NTRA) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
1/5
07:25 pm
ntra
Natera Presents Updated Analyses From ALTAIR Clinical Trial at ASCO GI
Medium
Report
Natera Presents Updated Analyses From ALTAIR Clinical Trial at ASCO GI
1/5
10:16 am
ntra
Natera (NASDAQ:NTRA) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Natera (NASDAQ:NTRA) had its "buy" rating reaffirmed by analysts at Guggenheim.
1/5
07:00 am
ntra
Natera Launches 21-Gene Fetal Focus™ Single-Gene NIPT, Powered By Ultra-Sensitive LinkedSNP™ Technology
Medium
Report
Natera Launches 21-Gene Fetal Focus™ Single-Gene NIPT, Powered By Ultra-Sensitive LinkedSNP™ Technology
1/3
05:42 am
ntra
Natera (NASDAQ:NTRA) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Medium
Report
Natera (NASDAQ:NTRA) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
12/31
12:08 pm
ntra
Natera (NTRA) Announces Publication of Findings from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study [Yahoo! Finance]
Low
Report
Natera (NTRA) Announces Publication of Findings from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study [Yahoo! Finance]
12/22
08:02 am
ntra
Natera (NASDAQ:NTRA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $250.00 to $285.00. They now have a "buy" rating on the stock.
Low
Report
Natera (NASDAQ:NTRA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $250.00 to $285.00. They now have a "buy" rating on the stock.
12/22
08:00 am
ntra
Natera to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Natera to Participate in the 44th Annual J.P. Morgan Healthcare Conference
12/18
08:00 am
ntra
Natera Announces Publication of Signatera™ Analysis from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study in Colorectal Cancer
Low
Report
Natera Announces Publication of Signatera™ Analysis from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study in Colorectal Cancer